pillbase.ru

Votrient

Active substance: pazopanib

pazopanib

Centralised EU authorisationActive

Marketing holder: Novartis Europharm Limited

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 10
  • Pazopanib
    TABLET, FILM COATED · PAZOPANIB HYDROCHLORIDE 200 mg/1
    42291-939
    AvKARE
  • Pazopanib
    TABLET, FILM COATED · PAZOPANIB HYDROCHLORIDE 200 mg/1
    0480-4184
    Teva Pharmaceuticals, Inc.
  • Pazopanib
    TABLET · PAZOPANIB 200 mg/1
    51407-872
    Golden State Medical Supply, Inc.
  • Pazopanib
    TABLET · PAZOPANIB 200 mg/1
    60505-4779
    Apotex Corp.
  • Pazopanib
    TABLET, FILM COATED · PAZOPANIB HYDROCHLORIDE 200 mg/1
    59651-582
    Aurobindo Pharma Limited
All products in this country (10)
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-f783-703a-ad7f-9f0ab97d11a5,01a1208d-1664-7aea-98ee-0908c355b8f7,01a1208d-bb73-7cfa-850e-ab3180bd8d3a,01a1208f-8d26-77b2-b841-ffe05e5651fe,01a12091-147a-7866-827b-9e8afb1dc5ad;count=10 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/001141
Registration status
Active
ATC code
L01XE11
Sources
  • product · EMA · EMEA/H/C/001141 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/001141 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/001141 · Verified 2026-10-09